Scientific research, design and development of personalized whole tumor-derived cell-based autologous immunotherapies for the treatment of cancers; providing a proprietary technology platform for the development of pharmaceutical products and devices featuring technology capable of eliciting anti-tumor responses via the release of tumor antigenic signatures and immunostimulatory factors that activate the adaptive immune system against tumor cells

'activ':55 'adapt':57 'anti':41 'anti-tumor':40 'antigen':49 'autolog':15 'base':14 'cancer':21 'capabl':37 'cell':13,62 'cell-bas':12 'deriv':11 'design':3 'develop':5,29 'devic':34 'elicit':39 'factor':53 'featur':35 'immun':58 'immunostimulatori':52 'immunotherapi':16 'person':7 'pharmaceut':31 'platform':26 'product':32 'proprietari':24 'provid':22 'releas':46 'research':2 'respons':43 'scientif':1 'signatur':50 'system':59 'technolog':25,36 'treatment':19 'tumor':10,42,48,61 'tumor-deriv':9 'via':44 'whole':8

GOLDSPIRE

Owners

Goods & Services